Premium Quality Ini-1 – Mmab Tool [0CeorBS5]
Premium Quality Ini-1 – Mmab Tool [0CeorBS5] is a cutting-edge monoclonal antibody designed for precision research and diagnostics. This mouse-derived antibody offers exceptional specificity and affinity, making it an invaluable tool in the laboratory. Highly Concentrated: INI-1 is
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Premium Quality Ini-1 – Mmab Tool [0CeorBS5] is a cutting-edge monoclonal antibody designed for precision research and diagnostics. This mouse-derived antibody offers exceptional specificity and affinity, making it an invaluable tool in the laboratory.
- Highly Concentrated: INI-1 is concentrated for enhanced performance.
- Filter Sterilized: Ensures purity and safety for your experiments.
Product Properties
INI-1 is meticulously prepared from cell culture supernatant. It undergoes a rigorous purification process, including concentration, dialysis, and filter sterilization, resulting in a high-quality antibody solution. This product is diluted in a buffer with a pH of 7.5, containing BSA and sodium azide as preservatives to maintain stability and longevity.- BSA-Free Option: Available upon request for specific applications.
- Low Endotoxin Levels: Ensures reliable results.
Applications and Benefits
Premium Quality Ini-1 – Mmab Tool [0CeorBS5] is a versatile tool suitable for various research and diagnostic applications. Whether you're conducting cell-based assays, immunoassays, or protein analysis, this antibody can provide accurate and consistent results.- Research: Ideal for immunocytochemistry, flow cytometry, and western blotting.
- Diagnostics: Offers a sensitive and specific detection method for various antigens.
What Our Customers Say
Absolutely no complaints!
The product is a great stress-free solution.
- Stress_Free_Living.
Absolutely no complaints!
I appreciate the smart design choices.
- Dennis Baker.
Absolutely no complaints!
A brilliant purchase that I'd make again in a heartbeat.
- Christopher Flores.